此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

GERAS Frailty Rehabilitation at Home During COVID-19

2022年3月4日 更新者:Alexandra Papaioannou、McMaster University

GERAS Frailty Rehabilitation at Home: Virtual Bundled Care for Seniors Who Are Frail to Build Strength and Resilience During COVID-19

The coronavirus disease 2019 (COVID-19) pandemic is keeping people apart, which can take a toll on physical and mental health. Many healthcare professionals are concerned vulnerable seniors may become deconditioned, which substantially increases risk of health complications and need for hospitalization. To address the immediate impact of COVID-19 policies (i.e., physical distancing, reduced access to care), the GERAS Frailty Rehabilitation model will be adapted to be delivered remotely in the homes of vulnerable seniors. The investigators' aim is to understand how to best build resilience among vulnerable seniors in the community through at-home rehabilitation services (socialization, exercise, nutrition, and medication support).

研究概览

详细说明

During this unprecedented time of COVID-19, many healthcare professionals are concerned that vulnerable seniors who are housebound and isolated will become deconditioned resulting in functional losses in mental status, continence and ability to complete activities of daily living. Total inactivity in seniors can result in a 10-20% decrease in muscle strength per week (1 -3% per day). Loss of muscle strength may quickly convert a vulnerable older adult who was ambulatory into a bedridden state. This will affect the health of seniors and increase demand on healthcare systems. An innovative model to deliver frailty rehabilitation services remotely is urgently needed to: 1) increase access to specialized services 2) provide added supports for seniors discharged from the hospital who are in need of rehabilitation and 3) build resilience in seniors to prevent re-hospitalization or institutionalization. Therefore, to address the immediate impact of COVID-19 policies (i.e., physical distancing and reduced access to care), the GERAS Frailty Rehabilitation model will be adapted to be delivered remotely in the homes of vulnerable seniors. This proof-of-concept, randomized control trial aims to understand how to best build resilience among vulnerable seniors through at-home rehabilitation services using socialization, exercise, nutrition, and medication support.

The short-term immediate goals for this RCT are to help vulnerable seniors who are isolated because of physical distancing measures to build strength and resilience throughout the COVID-19 pandemic. The major deliverables are 1) the adaptation of an in-person program to virtual delivery 2) the piloting of a care pathway with inter-disciplinary professionals that can be expanded to reach a larger number of individuals.

The long-term goal of the study is the seamless implementation of a new model for multimodal Frailty Rehabilitation that closes the care gap in rehabilitation for frail seniors in the immediate and foreseeable future.

研究类型

介入性

注册 (实际的)

70

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Ontario
      • Hamilton、Ontario、加拿大、L8M1W9
        • McMaster University - Hamilton Health Sciences (St. Peter's Site)

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

65年 及以上 (年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Community-dwelling adults aged ≥ 65 years of age;
  • Score between 4-6 (inclusive) on the clinical frailty scale;
  • Able to ambulate independently with or without a walking aid; OR with caregiver supervision at home;
  • Obtain clearance for exercise: For hospital referrals - average resting heart rate between 50-100 bpm and average blood pressure less than or equal to 160/90mmHg (as per Canadian Society for Exercise Physiology guidelines for exercise clearance); OR Self- referrals: Obtain exercise clearance from their family physician prior to the first intervention session.

Exclusion Criteria:

  • Unable to speak or understand English and has no caregiver for translation;
  • Significant cognitive impairment where they may have difficulty following two-step commands;
  • Receiving palliative/end of life care;
  • Unstable angina or unstable heart failure;
  • Travel plans that would result in missing greater than 20% of the trial's 12-week duration;
  • Currently attending a group exercise program.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
有源比较器:Socialization
Participants randomized to the socialization arm will receive once-weekly phone calls from medical student volunteers for a total of 12-weeks (n=35). This program pairs health professional student volunteers with older adults in the community to provide social comfort while heightened physical distancing measures are in place during the current COVID-19 pandemic. Attendance and duration of the phone calls will be logged.
Social interaction is associated with better mental and physical health, and evidence suggests that group versus individual engagement may offer unique cognitive benefits for older adults as well as peer reinforcement and encouragement.
实验性的:Multi-Modal Frailty Rehabilitation
Multi-modal frailty rehabilitation will involve virtual care including 1x/week socialization, 2x/week exercise (small group physiotherapy live-streamed sessions), nutrition (virtual consult), and medication support (virtual pharmacist consult) all through a videoconferencing system.
Social interaction is associated with better mental and physical health, and evidence suggests that group versus individual engagement may offer unique cognitive benefits for older adults as well as peer reinforcement and encouragement.
Participants will receive twice-weekly (one hour per class) virtual exercise via small-group physiotherapy sessions for a total of 12 weeks. All exercise sessions will occur virtually via a videoconferencing system. The classes will focus on functional movements specifically designed for seniors with frailty and mobility challenges, and will include modifications for gait aids such as canes or walkers. Class sizes will be small to allow for tailoring of exercises based on challenging, safe, progressive, evidence-based exercises. In accordance with recent guidelines to achieve 3 hours/week for fall prevention practice in older adults, participants will also be provided with tailored supplemental home exercises developed by the study physiotherapist to gain an additional 1 hour of physical activity.

Nutrition Consult: Participants will be scheduled for a one-on-one virtual nutrition consult. During the consultation, study staff will assess the nutritional status of the participant and will provide them with counselling and coaching to improve their nutrition.

Protein Supplementation: Oral nutrition supplements commercially available from Nestle will be provided unless contraindicated. The oral nutrition supplement contains 360 calories and 14 grams of protein per serving. Participants are advised to take this with a meal or within 3 hours of exercise on activity days.

A study pharmacist will review the participant's medication list and will utilize Beers and/or START/STOPP criteria to provide recommendations to optimize/update their medications to the participant's healthcare provider. Study geriatricians will be listed as contacts on the primary care provider recommendations and available for consultation.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Physical Function
大体时间:Baseline and 12 Weeks Post-Intervention
Assessed by the 5x Sit-to-Stand (time to complete). Faster times to complete indicate better performance.
Baseline and 12 Weeks Post-Intervention
Change in Mental Health
大体时间:Baseline and 12 Weeks Post-Intervention
Assessed by the Depression Anxiety Stress Scale (DASS-21). Higher scores indicate greater risk of depression, anxiety and stress [depression, anxiety, stress subscores range 0-21].
Baseline and 12 Weeks Post-Intervention

次要结果测量

结果测量
措施说明
大体时间
Change in Sarcopenia
大体时间:Baseline and 12 Weeks Post-Intervention
Assessed by the SARC-F - Self-reported strength, assistance with walking, rising from a chair, climbing stairs and falls. Higher scores indicate greater level of sarcopenia [range 0-10].
Baseline and 12 Weeks Post-Intervention
Change in Frailty
大体时间:Baseline and 12 Weeks Post-Intervention
Assessed by the Fit-Frailty Index. Higher scores indicate greater degree of frailty [range 0-1].
Baseline and 12 Weeks Post-Intervention
Change in Self-Efficacy
大体时间:Baseline and 12 Weeks Post-Intervention
Balance confidence will be assessed using the Activities-specific Balance Confidence Scale (ABCs). Higher scores indicate greater balance confidence [range 0-100].
Baseline and 12 Weeks Post-Intervention
Self-Reported Change in Function, Health and Well-Being
大体时间:Baseline and 12 Weeks Post-Intervention
Assessed by the interRAI Community Rehab Assessment - Self-Report
Baseline and 12 Weeks Post-Intervention
Clinician-Reported Change in Function, Health and Well-Being
大体时间:Baseline and 12 Weeks Post-Intervention
Assessed by the interRAI Community Rehab Assessment - Clinician-Completed
Baseline and 12 Weeks Post-Intervention
Change in Fitness
大体时间:Weekly up to 12 weeks
Assessed by the Borg Rate of Perceived Exertion after exercise. Higher scores indicate greater level of exertion [range 6-20]. Also assessed using accelerometers (heart rate, sedentary time, physical activity time, energy expenditure).
Weekly up to 12 weeks
Program Satisfaction
大体时间:12 Weeks Post-Intervention
Assessed using a program questionnaire in accordance with the Kirkpatrick 5-Level Evaluation Model. Scores will be on a 5-point Likert scale ranging from "Strongly Disagree" to "Strongly Agree".
12 Weeks Post-Intervention
Change in Health-Related Quality of Life
大体时间:Baseline and 12 Weeks Post-Intervention
Assessed by the EQ-5D-5L scale. Lower scores indicate better self-reported quality of life [range 0-100].
Baseline and 12 Weeks Post-Intervention
Change in Nutrition
大体时间:Baseline and 12 Weeks Post-Intervention
Assessed by the Subjective Global Assessment. Grades range from A-C where 'A' represents normal nutrition and 'C' represents severe malnourishment.
Baseline and 12 Weeks Post-Intervention
Change in Emergency Room Visits
大体时间:Baseline and 12 Weeks Post-Intervention
Number of emergency room visits will be recorded. Higher number of emergency room visits indicates higher healthcare utilization.
Baseline and 12 Weeks Post-Intervention
Change in Hospitalizations
大体时间:Baseline and 12 Weeks Post-Intervention
Number of hospitalizations will be recorded. Higher number of hospitalizations indicates higher healthcare utilization.
Baseline and 12 Weeks Post-Intervention
Change in Number of Calls to 911
大体时间:Baseline and 12 Weeks Post-Intervention
Number of calls to 911 will be recorded. Higher number of calls indicates higher healthcare utilization.
Baseline and 12 Weeks Post-Intervention

其他结果措施

结果测量
措施说明
大体时间
Feasibility Outcome #1 - Reach of intervention
大体时间:12 Weeks Post-Intervention
Assessed by the number of individuals who participated. Target reach is 70 participants.
12 Weeks Post-Intervention
Feasibility Outcome #2 - Adoption of the Intervention
大体时间:12 Weeks Post-Intervention
Assessed by number of referral sites. Target is 5 referral sites.
12 Weeks Post-Intervention
Feasibility Outcome #3 - Implementation of the Intervention
大体时间:12 Weeks Post-Intervention
Assessed by the number of individuals who completed the intervention. Higher number of individuals completing the study indicates greater success in implementation.
12 Weeks Post-Intervention
Feasibility Outcome #4 - Maintenance of the Intervention
大体时间:12 Weeks Post-Intervention
Assessed by the number of referral sites continuing with a second cohort. Greater number of referral sites continuing with a second cohort indicates greater maintenance.
12 Weeks Post-Intervention

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Alexandra Papaioannou, MD, MSc、Scientific Director, GERAS Centre for Aging Research

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2020年8月26日

初级完成 (实际的)

2021年11月1日

研究完成 (实际的)

2021年11月1日

研究注册日期

首次提交

2020年7月31日

首先提交符合 QC 标准的

2020年8月4日

首次发布 (实际的)

2020年8月5日

研究记录更新

最后更新发布 (实际的)

2022年3月7日

上次提交的符合 QC 标准的更新

2022年3月4日

最后验证

2022年3月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅